Moderna target nearly halved by Morgan Stanley on weak guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 197.00 +0.52 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $196.48 | 52 Week High | $0.52 | |||
| Open | $196.42 | 52 Week Low | $0.08 | |||
| Day High | $199.92 | P/E | N/A | |||
| Day Low | $192.71 | EPS | $-3.80 | |||
| Volume | 37,407,162 | |||||
| Morgan Stanley (NYSE: MS) | Delayed: 187.44 -2.27 (1.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $189.71 | 52 Week High | $39.88 | |||
| Open | $186.81 | 52 Week Low | $21.16 | |||
| Day High | $188.54 | P/E | 131.08 | |||
| Day Low | $186.15 | EPS | $1.43 | |||
| Volume | 5,860,162 | |||||
